Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Kelly

Showing results (111-120 of 221) with videos related to

Pageof 23
Sort By:
The Journal of Infectious Diseases|May 4, 2012
Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single populationAna Maria Mejia, Belinda S Hall, Martin C Taylor, et al.
Chemical Communications (Cambridge, England)|July 17, 2020
Water-soluble amphiphilic ruthenium(ii) polypyridyl complexes as potential light-activated therapeutic agentsSandra Estalayo-Adrián, Salvador Blasco, Sandra A Bright, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 1, 2018
Synthesis, anti-bacterial and anti-protozoal activities of amidinobenzimidazole derivatives and their interactions with DNA and RNAAndrea Bistrović, Luka Krstulović, Ivana Stolić, et al.
Molecular and Biochemical Parasitology|March 30, 2006
The suppression of galactose metabolism in Trypanosoma cruzi epimastigotes causes changes in cell surface molecular architecture and cell morphologyJames I MacRae, Samson O Obado, Daniel C Turnock, et al.
Cellular Microbiology|April 10, 2014
Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infectionMichael D Lewis, Amanda Fortes Francisco, Martin C Taylor, et al.
Pediatric Cardiology|November 8, 2020
Evaluating the Longevity of the Fontan PathwayJohn M Kelly, Gabriel J M Mirhaidari, Yu-Chun Chang, et al.
Current Pharmaceutical Design|February 11, 2020
Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR StudyVasiliki Pardali, Erofili Giannakopoulou, Dimitrios-Ilias Balourdas, et al.
Medchemcomm|July 16, 2019
Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of <i>Flaviviridae</i> viruses and <i>Trypanosoma</i> speciesErofili Giannakopoulou, Vasiliki Pardali, Efseveia Frakolaki, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 15, 2019
Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite InteractionsMartin C Taylor, Amanda F Francisco, Shiromani Jayawardhana, et al.
Pediatric Cardiology|November 1, 2024
Ectopic Calcification in Congenital Heart Surgery: A Material-Centric ReviewTatsuya Watanabe, Satoshi Yuhara, Joseph T Leland, et al.
Pageof 23

Showing results (111-120 of 221) with videos related to

Sort By:
Pageof 23
The Journal of Infectious Diseases|May 4, 2012
Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single populationAna Maria Mejia, Belinda S Hall, Martin C Taylor, et al.
Chemical Communications (Cambridge, England)|July 17, 2020
Water-soluble amphiphilic ruthenium(ii) polypyridyl complexes as potential light-activated therapeutic agentsSandra Estalayo-Adrián, Salvador Blasco, Sandra A Bright, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 1, 2018
Synthesis, anti-bacterial and anti-protozoal activities of amidinobenzimidazole derivatives and their interactions with DNA and RNAAndrea Bistrović, Luka Krstulović, Ivana Stolić, et al.
Molecular and Biochemical Parasitology|March 30, 2006
The suppression of galactose metabolism in Trypanosoma cruzi epimastigotes causes changes in cell surface molecular architecture and cell morphologyJames I MacRae, Samson O Obado, Daniel C Turnock, et al.
Cellular Microbiology|April 10, 2014
Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infectionMichael D Lewis, Amanda Fortes Francisco, Martin C Taylor, et al.
Pediatric Cardiology|November 8, 2020
Evaluating the Longevity of the Fontan PathwayJohn M Kelly, Gabriel J M Mirhaidari, Yu-Chun Chang, et al.
Current Pharmaceutical Design|February 11, 2020
Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR StudyVasiliki Pardali, Erofili Giannakopoulou, Dimitrios-Ilias Balourdas, et al.
Medchemcomm|July 16, 2019
Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of <i>Flaviviridae</i> viruses and <i>Trypanosoma</i> speciesErofili Giannakopoulou, Vasiliki Pardali, Efseveia Frakolaki, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 15, 2019
Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite InteractionsMartin C Taylor, Amanda F Francisco, Shiromani Jayawardhana, et al.
Pediatric Cardiology|November 1, 2024
Ectopic Calcification in Congenital Heart Surgery: A Material-Centric ReviewTatsuya Watanabe, Satoshi Yuhara, Joseph T Leland, et al.
Pageof 23